Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP-C1 in metastatic breast cancer
NCT03789019Phase 2Completed
- Sponsor
- Meabco A/S
- Start
- Feb 2013
- Primary completion
- Jul 2016
- Modality
- Polymer-based Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of BP-C1 in breast cancer, sponsored by Meabco A/S. Started Feb 2013; status: completed.
02
Drugs
BP-C1
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03789019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789019.